secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemours Co (CC)
CIK:        0001627223
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001193125-24-061056
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemours: senior management delayed payables, accelerated receivables to meet cash targets; material weaknesses expected
--------------------------------------------------------------------------------

- Senior management placed on administrative leave for delaying vendor payments from Q4 2023 to Q1 2024 and accelerating receivables into Q4 2023 to meet free cash flow targets.
- Audit Committee found violations of Code of Ethics for lack of transparency with Board; similar but lesser actions taken in Q4 2022.
- Preliminary FY2023 unaudited results unaffected; cash and equivalents $1.8B ($1.2B unrestricted) as of Dec 31, 2023.
- Company expects to report material weaknesses in internal control over financial reporting as of Dec 31, 2023, including tone at the top and hotline controls.
- Anonymous hotline report not escalated to General Counsel or Audit Committee until year-end external audit process; inadequate controls identified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1627223/000119312524061056/0001193125-24-061056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1627223/000119312524061056/d806416d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-061056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer